Severe sepsis in a premature neonate: protein C replacement therapy

Treatment with activated protein C has been shown to reduce mortality in adult patients with severe sepsis but also to increase risk of bleeding. In patients with predisposition to bleeding, as in preterm infants, the inactivated form of protein C could serve as a safe therapeutic option. We...

Full description

Saved in:
Bibliographic Details
Main Authors: Maria Pia De Carolis, Valentina Polimeni, Patrizia Papacci, Serafina Lacerenza, Costantino Romagnoli
Format: Article
Language:English
Published: Hacettepe University Institute of Child Health 2008-08-01
Series:The Turkish Journal of Pediatrics
Online Access:https://turkjpediatr.org/article/view/2457
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850236446980440064
author Maria Pia De Carolis
Valentina Polimeni
Patrizia Papacci
Serafina Lacerenza
Costantino Romagnoli
author_facet Maria Pia De Carolis
Valentina Polimeni
Patrizia Papacci
Serafina Lacerenza
Costantino Romagnoli
author_sort Maria Pia De Carolis
collection DOAJ
description Treatment with activated protein C has been shown to reduce mortality in adult patients with severe sepsis but also to increase risk of bleeding. In patients with predisposition to bleeding, as in preterm infants, the inactivated form of protein C could serve as a safe therapeutic option. We report the case of a preterm neonate who developed severe sepsis on the 28th day of life, who was successfully treated with the inactivated form of protein C for a period of 96 hours.
format Article
id doaj-art-dd2185a23ced4b628df665b3f21a8a49
institution OA Journals
issn 0041-4301
2791-6421
language English
publishDate 2008-08-01
publisher Hacettepe University Institute of Child Health
record_format Article
series The Turkish Journal of Pediatrics
spelling doaj-art-dd2185a23ced4b628df665b3f21a8a492025-08-20T02:01:57ZengHacettepe University Institute of Child HealthThe Turkish Journal of Pediatrics0041-43012791-64212008-08-01504Severe sepsis in a premature neonate: protein C replacement therapyMaria Pia De Carolis0Valentina PolimeniPatrizia PapacciSerafina LacerenzaCostantino RomagnoliDivision of Neonatal Intensive Care, Department of Pediatrics, Catholic University of Sacred Heart, Rome, Italy. Treatment with activated protein C has been shown to reduce mortality in adult patients with severe sepsis but also to increase risk of bleeding. In patients with predisposition to bleeding, as in preterm infants, the inactivated form of protein C could serve as a safe therapeutic option. We report the case of a preterm neonate who developed severe sepsis on the 28th day of life, who was successfully treated with the inactivated form of protein C for a period of 96 hours. https://turkjpediatr.org/article/view/2457
spellingShingle Maria Pia De Carolis
Valentina Polimeni
Patrizia Papacci
Serafina Lacerenza
Costantino Romagnoli
Severe sepsis in a premature neonate: protein C replacement therapy
The Turkish Journal of Pediatrics
title Severe sepsis in a premature neonate: protein C replacement therapy
title_full Severe sepsis in a premature neonate: protein C replacement therapy
title_fullStr Severe sepsis in a premature neonate: protein C replacement therapy
title_full_unstemmed Severe sepsis in a premature neonate: protein C replacement therapy
title_short Severe sepsis in a premature neonate: protein C replacement therapy
title_sort severe sepsis in a premature neonate protein c replacement therapy
url https://turkjpediatr.org/article/view/2457
work_keys_str_mv AT mariapiadecarolis severesepsisinaprematureneonateproteincreplacementtherapy
AT valentinapolimeni severesepsisinaprematureneonateproteincreplacementtherapy
AT patriziapapacci severesepsisinaprematureneonateproteincreplacementtherapy
AT serafinalacerenza severesepsisinaprematureneonateproteincreplacementtherapy
AT costantinoromagnoli severesepsisinaprematureneonateproteincreplacementtherapy